---
title: 'High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks'' Gestation
  and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial'
date: '2023-11-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37983037/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231121171234&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: In this follow-up of a randomized clinical
  trial, enteral DHA supplementation at the equivalent of the estimated in utero dose
  for infants born at less than 29 weeks'' gestation did not improve behavioral functioning
  at age 5 years. There were no indications of adverse effects with DHA ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: In this follow-up of a randomized clinical trial, enteral DHA supplementation at the equivalent of the estimated in utero dose for infants born at less than 29 weeks' gestation did not improve behavioral functioning at age 5 years. There were no indications of adverse effects with DHA ...